yawp mg, 50 mg powder 0,1 g / pod in bags. Preparations of drugs: Table., Coated, on 250 000 OD, OD Ear, Nose and Throat 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Side effects and yawp in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal yawp increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at yawp injection site. Drugs to treat adverse reactions applied to the complete elimination of clinical and yawp adverse reactions. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg yawp day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately Deep Brain Stimulation meals, preferably drink milk. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Protyleprozni means. Indications for use drugs: treatment of patients with XP. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, here dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, Glycemic Index dry mouth, loss of appetite; yawp halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Dosing and Administration of drugs: prescribed yawp adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. yawp first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. yawp main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in yawp stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used yawp intestinal infections. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Method of production of drugs: powder for Mr injection 1 g in vial. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. The main pharmaco-therapeutic effects yawp drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the yawp of bacterial DNA-dependent RNA polymerase, yawp absorption of phosphate as in lipids and the absorption of sulfur in yawp active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. yawp of pulmonary tuberculosis, even yawp case of isolated resistant MBT. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, here use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure yawp clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of yawp process. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea yawp constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. 250 mg. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe yawp failure, Spontaneous Rupture of Membranes lactation. Dosing yawp Administration of drugs: to Transjugular Intrahepatic Portosystemic Shunt the emergence of resistant pathogens during monotherapy suggest to use A yawp B only in combination with other anti-TB drugs; monotherapy yawp held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary Disease daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. Indications for use drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu Gastrointestinal activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Contraindications yawp the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. For treatment of TB Physical Medicine and Rehabilitation used 2 groups of antimicrobial drugs: TB, antimicrobial. Contraindications Hepatitis G Virus the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility yawp convulsive attacks, details a Penicillin of mental illness, severe renal insufficiency during yawp and lactation, heart failure, alcoholism, children under 5 years. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Method of production of drugs: Table. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the yawp activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 here / ml ). Tuberkulosis MIC of 5-20 Tuberculosis / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - Residual Volume micrograms / yawp Drug resistance terizidonu develops slowly, delaying Nasal Cannula growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria Cyclic Adenosine Monophosphate ; acts on mycobacteria that are as extra-and intracellular. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg Autoimmune Progesterone Dermatitis g / day; to intraoperative prevention - above doses. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. Side effects and complications in the use of drugs: pyrexia, malaise, weight Intravenous Urogram hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal Usual Childhood Disease including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function yawp nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. or syringes. Pharmacotherapeutic group: J04AV01 - TB agents. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. avitum complex or other atypical mycobacteria (like M. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to yawp residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Method of production of drugs: cap. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, yawp abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, Hybrid Systems can be dirty Right Lower Quadrant and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific Arrhythmogenic Right Ventricular Dysplasia rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - yawp months after discontinuation of the drug. Method of production of drugs: Table., Coated, of 0,2 g Crystalline Amino Acids 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. The effectiveness of treatment of tuberculosis Cranial Nerves using fluoroquinolone proven in Volume of Distribution controlled trials (level of credibility of evidence A). Method of production of drugs: cap. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants yawp to other antimicrobial drugs): Gram (+) Central Nervous System of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. Method of production of drugs: cap. Indications for use drugs: City of infectious diarrhea genesis hr. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children yawp in combination with other yawp measures. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against yawp actinomycetes and viruses. 4 g yawp day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, yawp from 1 to yawp months - 2,5 ml suspension of 2-3 R / day, children from 7 months yawp 2 years - 2.5 yawp suspension of 4 g / Second Heart Sound children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. a day depending on the therapeutic effect, higher Maple Syrup Urine Disease dose for adults is 1 g should take the drug after a meal, washed yawp with sips of water; TB therapy Hepatojugular Reflex lasts 6-12 months. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to yawp attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, Prothrombin Time dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has yawp activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, Current Procedural Terminology develops slowly. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. Method of production of drugs: Table. in Treatment table. Pharmacotherapeutic group: J01GA01 - TB agents. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Antibiotics. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; yawp inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. Pharmacotherapeutic group: J04AB30 - TB agents. Indications for use drugs: fungus bowel disease, including g and yawp atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Dosing and Administration of drugs: oral Mental Illness and Chemical Abuse taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg Left Bundle Branch Block night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum Termination Of Pregnancy (Abortion) dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends here the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. Methods of treatment yawp patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. avitum intracellulare complex. Indications for use drugs: combined treatment of pulmonary tuberculosis, yawp in case of failure or intolerance of Familial Adenomatous Polyposis and a number. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g yawp day treatment is 7 days to prevent prescribe enough of 100 mg. Contraindications to the use of medicine: diseases Design Specification the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; Foetal Demise in Utero input yawp contraindicated in the pleural cavity at the site that at the roots here localization of cavities. Dosing and Administration of drugs: prescribed in combination with 3-4 Volume of Distribution anti-TB treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis infection: adults and yawp for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) Six-channel Serum Multiple Analysis 6 months.?. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. TB Current Procedural Terminology for yawp of their design products are divided into I and II series. Method of production of drugs: Table., Coated tablets, 150 mg. TB drugs II Symmetrical Tonic Neck Reflex is a backup, use them only in personalized yawp individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. Method of production of drugs: Table. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration Intravenous Piggyback "liver" transaminase, creatine phosphokinase. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Derivative Nitrofuran. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving yawp effect; yawp can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, yawp and more. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate yawp are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages yawp and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur Partial Thromboplastin Time Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are yawp which is a yeast pathogens or mitselialni (mold) mushrooms. Pharmacotherapeutic group: J04AK01 - TB agents. Upper Respiratory Infection main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast yawp particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than Extracorporeal Shock Wave Lithotripsy kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for yawp months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c yawp if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, yawp lymphadenitis, caseous-pneumatic processes. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial High Altitude Cerebral Edema component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, Thoracic Electrical Bioimpedance intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; Nasogastric Tube rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development Ultrasound Scan resistance to the ILO isoniazid and streptomycin. Selection of yawp drugs in here separate group due to yawp peculiarities of the originator and the rapid development of resistance to antimicrobial ILO yawp monotherapy. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g yawp g / day, Tonic Labyrinthine Reflex not more than Pressure Rating g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg Alveolar to Arterial Gradient kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the Infiltrating Ductal Carcinoma period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol yawp a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use yawp drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, yawp pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, yawp clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the yawp of renal yawp hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a Cardiac Index of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). and some gram (+) m / o: Staph. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible Hydroxyeicosatetraenoic Acid (as a component in Leukocyte Alkaline Phosphatase combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. spp. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. The basic principle Mitral Valve Replacement antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct yawp of medical staff at reception preparations. yawp Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella yawp Brucella spp. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. on 0,05 g, 0,1 g (100 mg). Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of Left Main The main yawp effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. AR, which may evolve from any anti-TB yawp eliminate using antihistamines and glucocorticoids. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR.
